Yuan J et al. |
Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma. |
2005 |
Urology |
pmid:15780399
|
Park JM |
Role of prostaglandins in bladder smooth muscle cell gene expression. |
2001 |
Urology |
pmid:11378068
|
Jerde TJ et al. |
Celecoxib inhibits ureteral contractility and prostanoid release. |
2005 |
Urology |
pmid:15667901
|
Masuda H et al. |
15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats. |
2006 |
Urology |
pmid:16461118
|
Lee JJ et al. |
Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. |
2006 |
Vascul. Pharmacol. |
pmid:16916624
|
Hahn HL |
[Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy]. |
1988 |
Verh Dtsch Ges Inn Med |
pmid:2905102
|
BrazÃs P et al. |
Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release. |
2006 |
Vet. Dermatol. |
pmid:16674731
|
Gueck T et al. |
Influence of vitamin E on mast cell mediator release. |
2002 |
Vet. Dermatol. |
pmid:12464062
|
Lin TY and London CA |
Characterization and modulation of canine mast cell derived eicosanoids. |
2010 |
Vet. Immunol. Immunopathol. |
pmid:20036014
|
Cerrato S et al. |
Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. |
2010 |
Vet. Immunol. Immunopathol. |
pmid:19625089
|
Liu Y et al. |
Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection. |
2008 |
Vet. Immunol. Immunopathol. |
pmid:18394717
|
Yoshitake R et al. |
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines. |
2017 |
Vet. J. |
pmid:28283079
|
Arnold R and König W |
Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells. |
2006 |
Virology |
pmid:16616290
|
Arnold R and König W |
Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells. |
2006 |
Virology |
pmid:16330064
|
Boisvert M et al. |
PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells. |
2008 |
Virology |
pmid:18755491
|
Urade Y and Hayaishi O |
Prostaglandin D synthase: structure and function. |
2000 |
Vitam. Horm. |
pmid:10668396
|
Jović N et al. |
Do prostaglandins E2, F2 alpha and D2 have a role in the development of idiopathic trigeminal neuralgia? |
1996 May-Jun |
Vojnosanit Pregl |
pmid:9174396
|
Ma XM et al. |
Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma. |
2009 |
World J. Gastroenterol. |
pmid:19701967
|
Dong YW et al. |
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. |
2009 |
World J. Gastroenterol. |
pmid:19152448
|
Chen YX et al. |
15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line. |
2003 |
World J. Gastroenterol. |
pmid:14562367
|